PHARMACOKINETICS IN DRUG-THERAPY .2. APPLICATIONS OF CLINICAL PHARMACOKINETICS IN ASSESSMENT OF THEOPHYLLINE THERAPY

被引：11

作者：

FLOYD, RA ^{[1
]}

COHEN, JL ^{[1
]}

机构：

[1] UNIV SO CALIF,SCH PHARM,CLIN PHARMACOKINET LAB,LOS ANGELES,CA 90033

来源：

AMERICAN JOURNAL OF HOSPITAL PHARMACY | 1977年 / 34卷 / 04期

关键词：

D O I：

10.1093/ajhp/34.4.402

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：402 / 407

页数：6

共 27 条

[1] CORNISH HH, 1957, J BIOL CHEM, V228, P315
[2] ELLIS EF, 1975, NEW DIRECTIONS ASTHM, P317
[3] FLOYD R, 1976, American Review of Respiratory Disease, V113, P122
[4] HUNT SN, 1976, CLIN PHARMACOL THER, V19, P546
[5] CLINICAL EXPERIENCE WITH THEOPHYLLINE - RELATIONSHIPS BETWEEN DOSAGE, SERUM CONCENTRATION, AND TOXICITY
JACOBS, MH
SENIOR, RM
KESSLER, G
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1976, 235 (18): : 1983 - 1986
[6] DECREASED THEOPHYLLINE HALF-LIFE IN CIGARETTE SMOKERS
JENNE, J
NAGASAWA, H
MCHUGH, R
MACDONALD, F
WYSE, E
[J]. LIFE SCIENCES, 1975, 17 (02) : 195 - 198
[7] JENNE JW, 1974, J ALLERGY CLIN IMMUN, V53, P80
[8] JENNE JW, 1972, CLIN PHARMACOL THER, V13, P349
[9] JENNE JW, 1976, CLIN PHARMACOL THER, V19, P375
[10] JENNE JW, 1975, NEW DIRECTIONS ASTHM, P391